Get the Stockscreener App
11.99
6.11%
-0.78
After Hours:
11.50
-0.49
-4.09%
Regenxbio Inc stock is traded at $11.99, with a volume of 901.63K.
It is down -6.11% in the last 24 hours and up +14.96% over the past month.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
See More
Previous Close:
$12.77
Open:
$12.4
24h Volume:
901.63K
Relative Volume:
1.51
Market Cap:
$605.67M
Revenue:
$89.04M
Net Income/Loss:
$-241.08M
P/E Ratio:
-2.2795
EPS:
-5.26
Net Cash Flow:
$-194.72M
1W Performance:
-11.97%
1M Performance:
+14.96%
6M Performance:
+15.29%
1Y Performance:
+36.41%
1-Day Range:
$11.47
$12.45
1-Week Range:
$11.47
$13.69
52-Week Range:
$5.035
$13.93
Regenxbio Inc Stock (RGNX) Company Profile
Name
Regenxbio Inc
Sector
Industry
Phone
240-552-8181
Address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Compare RGNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RGNX
Regenxbio Inc
|
11.99 | 645.07M | 89.04M | -241.08M | -194.72M | -5.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Regenxbio Inc Stock (RGNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Buy → Neutral |
| Feb-07-25 | Resumed | Raymond James | Outperform |
| Nov-15-24 | Resumed | Morgan Stanley | Overweight |
| Oct-10-24 | Resumed | Raymond James | Outperform |
| Jun-07-24 | Initiated | Goldman | Buy |
| Mar-11-24 | Initiated | H.C. Wainwright | Buy |
| Mar-08-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-06-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-21-24 | Resumed | Raymond James | Outperform |
| Nov-01-23 | Initiated | Stifel | Buy |
| Jun-02-23 | Initiated | Robert W. Baird | Outperform |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Dec-15-21 | Initiated | Wedbush | Neutral |
| Oct-19-21 | Resumed | Morgan Stanley | Overweight |
| Jan-06-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Aug-20-19 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Jun-18-19 | Reiterated | Chardan Capital Markets | Buy |
| Jun-14-19 | Resumed | Raymond James | Outperform |
| Jun-05-19 | Reiterated | Chardan Capital Markets | Buy |
| Feb-25-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-05-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-17-18 | Reiterated | Chardan Capital Markets | Buy |
| Nov-08-18 | Reiterated | BofA/Merrill | Neutral |
| Aug-08-18 | Reiterated | Chardan Capital Markets | Buy |
| Jul-23-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-10-18 | Reiterated | Chardan Capital Markets | Buy |
| May-09-18 | Reiterated | Barclays | Overweight |
| Apr-09-18 | Reiterated | Chardan Capital Markets | Buy |
| Mar-12-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-13-18 | Initiated | Mizuho | Neutral |
| Nov-09-17 | Resumed | Morgan Stanley | Overweight |
View All
Regenxbio Inc Stock (RGNX) Latest News
Will REGENXBIO Inc. (RB0) stock profit from fiscal stimulusWeekly Gains Report & Community Verified Trade Alerts - newser.com
Will REGENXBIO Inc. (RB0) stock announce special dividendPortfolio Update Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Will REGENXBIO Inc. stock split again soonJobs Report & Short-Term Swing Trade Alerts - newser.com
REGENXBIO Inc. stock daily chart insightsJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Reversal indicators forming on REGENXBIO Inc. stock2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Will REGENXBIO Inc. stock go up soonJuly 2025 Trends & Short-Term Swing Trade Alerts - newser.com
What data driven models say about REGENXBIO Inc.’s future2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
Visualizing REGENXBIO Inc. stock with heatmapsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Will REGENXBIO Inc. stock see PE expansionQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Historical volatility pattern of REGENXBIO Inc. visualizedEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
Should I buy REGENXBIO Inc. (RB0) stock before earnings seasonTrade Analysis Report & Expert Curated Trade Setup Alerts - newser.com
Is REGENXBIO Inc. stock undervalued vs historical averagesGold Moves & Detailed Earnings Play Alerts - newser.com
Using Ichimoku Cloud for REGENXBIO Inc. technicals2025 Price Targets & AI Driven Stock Movement Reports - newser.com
Price momentum metrics for REGENXBIO Inc. explainedMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Analyzing recovery setups for REGENXBIO Inc. investorsMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Can REGENXBIO Inc. (RB0) stock deliver strong annual returnsWeekly Trade Summary & Growth-Oriented Investment Plans - newser.com
Why REGENXBIO Inc. stock is considered a top pickAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Why REGENXBIO Inc. stock appeals to dividend seekersPortfolio Value Summary & Long-Term Growth Plans - newser.com
Is REGENXBIO Inc. stock overvalued by current metricsCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Using economic indicators to assess REGENXBIO Inc. potentialWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - newser.com
AlphaQuest LLC Cuts Position in REGENXBIO Inc. $RGNX - MarketBeat
Is now a turning point for REGENXBIO Inc.Fed Meeting & Reliable Price Action Trade Plans - newser.com
REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
RegenXBio (RGNX) Receives a Buy from H.C. Wainwright - The Globe and Mail
Will REGENXBIO Inc. (RB0) stock outperform Dow Jones2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
Will REGENXBIO Inc. (RB0) stock sustain uptrend momentumInsider Selling & Technical Pattern Based Buy Signals - newser.com
REGENXBIO concludes subject enrolment in trial of RGX-202 - Clinical Trials Arena
Regenxbio Inc Stock (RGNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):